NYSE - Delayed Quote • USD
Dolby Laboratories, Inc. (DLB)
At close: April 18 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | 1.22 | 0.77 | 3.71 | 3.93 |
Low Estimate | 1.2 | 0.71 | 3.63 | 3.85 |
High Estimate | 1.23 | 0.82 | 3.75 | 3.98 |
Year Ago EPS | 1.26 | 0.55 | 3.56 | 3.71 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | 362.55M | 313.64M | 1.3B | 1.36B |
Low Estimate | 357.1M | 307.73M | 1.3B | 1.33B |
High Estimate | 369.54M | 316.84M | 1.3B | 1.4B |
Year Ago Sales | -- | -- | 1.3B | 1.3B |
Sales Growth (year/est) | -- | -- | 0.10% | 4.80% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.97 | 0.55 | 0.53 | 0.86 |
EPS Actual | 1.26 | 0.55 | 0.65 | 1.01 |
Difference | 0.29 | 0 | 0.12 | 0.15 |
Surprise % | 29.90% | 0.00% | 22.60% | 17.40% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 1.22 | 0.77 | 3.71 | 3.93 |
7 Days Ago | 1.22 | 0.77 | 3.71 | 3.93 |
30 Days Ago | 1.22 | 0.77 | 3.71 | 3.93 |
60 Days Ago | 1.2 | 0.77 | 3.7 | 3.95 |
90 Days Ago | 1.16 | 0.86 | 3.7 | 3.93 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | DLB | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -3.20% | -- | -- | 0.80% |
Next Qtr. | 40.00% | -- | -- | 9.60% |
Current Year | 4.20% | -- | -- | 4.50% |
Next Year | 5.90% | -- | -- | 13.30% |
Next 5 Years (per annum) | 16.00% | -- | -- | 11.09% |
Past 5 Years (per annum) | 6.72% | -- | -- | -- |
Research Analysis
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Reiterates | Rosenblatt: Buy to Buy | 1/31/2024 |
Reiterates | Rosenblatt: Buy to Buy | 12/11/2023 |
Reiterates | Rosenblatt: Buy to Buy | 11/17/2023 |
Maintains | Rosenblatt: Buy to Buy | 8/4/2023 |
Reiterates | Rosenblatt: Buy to Buy | 7/28/2023 |
Reiterates | Rosenblatt: Buy to Buy | 6/1/2023 |
Related Tickers
RTO Rentokil Initial plc
25.61
-9.35%
FA First Advantage Corporation
14.86
+0.61%
CBZ CBIZ, Inc.
74.22
+0.72%
ARMK Aramark
31.20
+0.13%
RBA RB Global, Inc.
72.49
-0.98%
CASS Cass Information Systems, Inc.
43.68
-2.35%
RELX RELX PLC
41.43
-0.05%
LZ LegalZoom.com, Inc.
11.81
-1.67%
ABM ABM Industries Incorporated
43.80
+0.37%
6544.T Japan Elevator Service Holdings Co.,Ltd.
2,359.00
-2.96%